These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30230580)

  • 1. DNA methylation in breast cancers: Differences based on estrogen receptor status and recurrence.
    Williams KE; Jawale RM; Schneider SS; Otis CN; Pentecost BT; Arcaro KF
    J Cell Biochem; 2019 Jan; 120(1):738-755. PubMed ID: 30230580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
    Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
    Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
    Sunami E; Shinozaki M; Sim MS; Nguyen SL; Vu AT; Giuliano AE; Hoon DS
    Breast Cancer Res; 2008; 10(3):R46. PubMed ID: 18485221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
    Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
    Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
    Fackler MJ; Umbricht CB; Williams D; Argani P; Cruz LA; Merino VF; Teo WW; Zhang Z; Huang P; Visvananthan K; Marks J; Ethier S; Gray JW; Wolff AC; Cope LM; Sukumar S
    Cancer Res; 2011 Oct; 71(19):6195-207. PubMed ID: 21825015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
    Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
    Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
    Di Cello F; Cope L; Li H; Jeschke J; Wang W; Baylin SB; Zahnow CA
    PLoS One; 2013; 8(7):e68630. PubMed ID: 23844228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
    Lapidus RG; Nass SJ; Butash KA; Parl FF; Weitzman SA; Graff JG; Herman JG; Davidson NE
    Cancer Res; 1998 Jun; 58(12):2515-9. PubMed ID: 9635570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
    Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
    Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity.
    Hill VK; Ricketts C; Bieche I; Vacher S; Gentle D; Lewis C; Maher ER; Latif F
    Cancer Res; 2011 Apr; 71(8):2988-99. PubMed ID: 21363912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.
    Chang HG; Kim SJ; Chung KW; Noh DY; Kwon Y; Lee ES; Kang HS
    J Mol Med (Berl); 2005 Feb; 83(2):132-9. PubMed ID: 15536519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
    Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer.
    Wang S; Dorsey TH; Terunuma A; Kittles RA; Ambs S; Kwabi-Addo B
    PLoS One; 2012; 7(5):e37928. PubMed ID: 22701537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
    Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
    J Cell Physiol; 2018 Sep; 233(9):7305-7319. PubMed ID: 29574992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
    Wei M; Xu J; Dignam J; Nanda R; Sveen L; Fackenthal J; Grushko TA; Olopade OI
    Breast Cancer Res Treat; 2008 Sep; 111(1):113-20. PubMed ID: 17932744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
    Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
    Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes.
    Pirouzpanah S; Taleban FA; Mehdipour P; Sabour S; Atri M
    Cancer Biomark; 2018 Feb; 21(3):621-638. PubMed ID: 29278880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Tiirikainen M; Yu H
    FEBS Open Bio; 2019 Jul; 9(7):1270-1280. PubMed ID: 31102318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas.
    Palmieri C; Rudraraju B; Monteverde M; Lattanzio L; Gojis O; Brizio R; Garrone O; Merlano M; Syed N; Lo Nigro C; Crook T
    Br J Cancer; 2012 Jul; 107(2):375-81. PubMed ID: 22644305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.